ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial

Thursday, September 3, 2015

Submitted by

Ruben Osnabrugge

Source

Source Name: Journal of the American College of Cardiology

Source URL: http://www.ncbi.nlm.nih.gov/pubmed/26292584

Author(s)

Arnold SV, Reynolds MR, Wang K, Magnuson EA, Baron SJ, Chinnakondepalli KM, Reardon MJ, Tadros PN, Zorn GL, Maini B, Mumtaz MA, Brown JM, Kipperman RM, Adams DH, Popma JJ, Cohen DJ

The authors of this study compared quality of life in patients at increased surgical risk who underwent either transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR). Quality of life was assesed in 795 randomized patients using the Kansas City Cardiomyopathy Questionnaire, the Medical Outcomes Study Short-Form 12 Questionnaire, and EuroQOL 5-dimension questionnaire. They found that quality of life at 1 year was similar in the two groups. However, sooner after the procedure (1 month) there was a quality of life benefit of femoral TAVR compared with SAVR. This early benefit over SAVR was not seen in patients that were treated with non-iliofemoral TAVR.